Earnings Document
-
•First quarter 2022 gross premiums written of
$1 billion evenly split between insurance and reinsurance on execution of strategic shift towards Insurance & Services -
• Strong contribution from
SiriusPoint's strategic partnerships
First Quarter 2022 Highlights
-
• Net loss of
$217 million , or$1.36 per diluted common share -
• Combined ratio of 93.7%, underwriting income of
$34 million -
• Tangible diluted book value per share decreased
$1.39 , or 10.5%, from the fourth quarter of 2021 to$11.88 -
• Core income of
$27 million , which includes underwriting income of$13 million , Core combined ratio of 97.5%, and Core net services income of$14 million -
• Catastrophe losses were
$7 million or 1 percentage point on the combined ratio;Russia /Ukraine losses of$19 million or 4 percentage points on the combined ratio -
•Net investment loss of
$205 million , including (15.3)% retufrom our investment in theThird Point Enhanced Fund -
•Annualized retuon average common equity of(39.5)%
Our investment results were disappointing and reducing volatility in our investment portfolio remains a strategic priority. We redeemed
We see positive momentum in our performance as we move towards the mid-point of the year. The capital position of the Company is strong, and we have a high degree of financial flexibility that allows for a responsive and nimble approach to market opportunities as we continue to grow Insurance & Services and our MGA relationships."
Key Financial Metrics
The following table shows certain key financial metrics for the three months ended
2021
($ in millions, except for per share data and ratios)
|
Combined ratio |
93.7 % |
96.5 |
% |
|
|
Core underwriting income (1) |
$ |
12.7 |
$ |
15.2 |
|
Core net services income (1) |
$ |
14.0 |
$ |
42.7 |
|
Core income (1) |
$ |
26.7 |
$ |
57.9 |
|
Core combined ratio (1) |
97.5 % |
93.7 |
% |
|
|
Annualized retuon average common shareholders' equity attributable to |
||||
|
shareholders |
(39.5)% |
33.9 |
% |
|
|
Basic book value per share (1) (2) |
$ |
13.05 |
$ |
14.46 |
|
Tangible basic book value per share (1) (2) |
$ |
11.99 |
$ |
13.38 |
|
Diluted book value per share (1) (2) |
$ |
12.94 |
$ |
14.33 |
|
Tangible diluted book value per share (1) (2) |
$ |
11.88 |
$ |
13.27 |
-
(1)Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures. See definitions in "Non-GAAP Financial Measures" and reconciliations in "Segment Reporting". Basic book value per share, tangible basic book value per share, diluted book value per share and tangible diluted book value per share are non-GAAP financial measures. See definitions and reconciliations in "Non-GAAP Financial Measures".
-
(2) Prior year comparatives represent amounts as of
December 31, 2021 .
FirstQuarter2022Summary
Consolidated underwriting income for the three months ended
Reportable Segments
The determination of our reportable segments is based on the manner in which management monitors the performance of our operations. In the fourth quarter of 2021, we began classifying our business into two reportable segments - Reinsurance and Insurance & Services.
Core Underwriting Results
Collectively, the sum of our two segments, Reinsurance and Insurance & Services, constitute our "Core" results. Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures.
See reconciliations in "Segment Reporting". We believe it is important to review Core results as it better reflects how management views the business and reflects our decision to exit the runoff business. The sum of Core results and Corporate results are equal to the consolidated results of operations.
Core results for the three months ended
For the three months ended
Reinsurance Segment
Reinsurance generated segment income of
Reinsurance gross premiums written were
Insurance & Services Segment
Insurance & Services generatedsegment income of
Insurance & Services gross premiums written were
Investments
Total realized and unrealized investment gains (losses) and net investment income (loss) was
Investment resultsfor the three months ended
Investment resultsforthe three months ended
Conference Call Details
The Company will hold a conference call to discuss its first quarter 2022 results at
A replay of the live conference call will be available approximately two hours after the call. The replay will be available on the Company's websiteatwww.siriuspt.comunder the "Investor Relations" section.
Safe Harbor Statement Regarding Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding optimizing capital allocation, rebalancing towards Insurance & Services and reducing our risk profile, creating a sustainable long-term franchise and future profitability. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. The Company cautions you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Actual events, results and outcomes may differ materially from the Company's expectations due to a variety of known and unknown risks, uncertainties and other factors. Among the risks and uncertainties that could cause actual results to differ from those described in the forward-looking statements are the following: our ability to execute on our strategic transformation, including changing the mix of business between insurance and reinsurance; the impact of the novel coronavirus ("COVID-19") pandemic or other unpredictable catastrophic events including uncertainties with respect to current and future COVID-19 losses across many classes of insurance business and the amount of insurance losses that may ultimately be ceded to the reinsurance market, supply chain issues, labor shortages and related increased costs, changing interest rates, equity market volatility and ongoing business and financial market impacts of COVID-19; the costs, expenses and difficulties of the integration of the operations of
Non-GAAP Financial Measures and Other Financial Metrics
In presenting
About the Company
Contacts
Investor Relations
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer



Q1 2022 Reinsurance Update
RENAISSANCERE HOLDINGS LTD – 10-Q – MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Advisor News
- Strong underwriting: what it means for insurers and advisors
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
More Advisor NewsAnnuity News
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
- Retirement is increasingly defined by a secure income stream
More Annuity NewsHealth/Employee Benefits News
- Health insurance legislation signed into law by Reynolds
- Researchers from Virginia Commonwealth University Report on Findings in Substance Abuse (Health insurance type moderates the association between substance use disorders and cardiovascular multimorbidity among U.S. adults – Results from the 2023 …): Addiction Research – Substance Abuse
- New Findings from Fudan University Describe Advances in Beta-Lactam Antibiotics (Budget impact analysis of aztreonam-avibactam for metallo-b-lactamase carbapenem-resistant enterobacterales infections in China): Drugs and Therapies – Beta-Lactam Antibiotics
- 4 major class action settlements could put cash in your pocket — See if you qualify
- A LOOK AT NEW OR EXPANDED MEDICAID AND PUBLIC HEALTH PARTNERSHIPS FROM 2025: FINDINGS FROM A SURVEY OF STATE MEDICAID PROGRAMS
More Health/Employee Benefits NewsLife Insurance News
- 5 steps to take before selling your firm
- Bismarck man pleads guilty to taking out insurance policy on dead wife
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- U-Haul Holding Company Schedules Fourth Quarter Fiscal Year End 2026 Financial Results Release and Investor Webcast
- New Empathy and LIMRA Research: The Overlooked Opportunity to Engage the Next Generation After an Insurance Payout
More Life Insurance News